Targeting the Biology of Aging with Peptides
The science of aging has undergone a fundamental shift. Once viewed as passive decay, aging is now understood as a set of identifiable, measurable, and potentially modifiable biological processes. López-Otín et al. (2013) codified these into nine hallmarks of aging, providing a framework for targeted intervention research. Four peptide-based compounds — Epithalon, NAD+, MOTS-c, and SS-31 — each target specific hallmarks, making them central tools in modern longevity research.
Epithalon: Telomere Biology
Background
Epithalon (also spelled Epitalon; sequence: Ala-Glu-Asp-Gly) is a synthetic tetrapeptide based on the natural pineal gland extract Epithalamin, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It targets one of the most fundamental mechanisms of cellular aging: telomere shortening.
Mechanisms
Telomerase activation: Epithalon activates telomerase — the enzyme that maintains telomere length — in human somatic cells (Khavinson et al., 2003). Telomeres are the protective nucleotide sequences at chromosome ends that shorten with each cell division. When telomeres reach a critical length, cells enter senescence or undergo apoptosis. By activating telomerase, Epithalon addresses one of the nine hallmarks of aging at its molecular root.
Melatonin regulation: Epithalon stimulates melatonin production by the pineal gland, restoring the circadian rhythm regulation that deteriorates with age (Anisimov et al., 2001). Melatonin is both a sleep-regulating hormone and a potent antioxidant, and its decline with age is associated with disrupted sleep, reduced antioxidant defense, and impaired immune function.
Lifespan extension: In rodent studies, chronic Epithalon administration was associated with a 13.6% increase in mean lifespan and delayed onset of age-related tumors (Anisimov et al., 2003). These are among the most significant lifespan extension results achieved by a peptide compound in mammalian models.
Gene expression: Epithalon modulates expression of genes involved in cell cycle regulation, oxidative stress defense, and apoptosis, suggesting effects beyond direct telomerase activation (Khavinson & Malinin, 2005).
NAD+: The Cellular Energy Currency
Background
Nicotinamide adenine dinucleotide (NAD+) is not a peptide in the traditional sense — it is a dinucleotide coenzyme essential for hundreds of metabolic reactions. It is included in longevity peptide research because of its central role in sirtuin activation and its dramatic age-related decline, making it a cornerstone of aging biology.
Mechanisms
Sirtuin activation: NAD+ is the essential cofactor for the sirtuin family (SIRT1-7) of deacetylase enzymes. Sirtuins regulate DNA repair (SIRT1, SIRT6), mitochondrial biogenesis (SIRT1, SIRT3), inflammatory responses (SIRT1), and metabolic homeostasis (SIRT1, SIRT3). Without adequate NAD+, sirtuin activity collapses (Imai & Guarente, 2014).
Age-related decline: NAD+ levels decline approximately 50% between ages 40 and 60 in key tissues. This decline is driven by increased activity of NAD+-consuming enzymes (CD38, PARP) and decreased biosynthesis (Camacho-Pereira et al., 2016).
PARP-mediated DNA repair: NAD+ fuels poly-ADP-ribose polymerase (PARP) enzymes that repair single-strand DNA breaks. As DNA damage accumulates with age, PARP activity increases, consuming more NAD+ and creating a metabolic deficit that impairs other NAD+-dependent processes.
Mitochondrial biogenesis: Through SIRT1 activation of PGC-1α, adequate NAD+ promotes the creation of new mitochondria, counteracting the decline in mitochondrial density and function that characterizes aging tissues (Gomes et al., 2013).
MOTS-c: The Mitochondrial Signaling Peptide
Background
MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome — specifically the 12S rRNA gene. Discovered by Lee et al. (2015) at the University of Southern California, MOTS-c was one of the first identified mitochondrial-derived peptides (MDPs) with systemic hormone-like activity.
Mechanisms
AMPK activation: MOTS-c activates AMP-activated protein kinase, the master energy sensor and metabolic regulator. AMPK activation promotes glucose uptake, fatty acid oxidation, and mitochondrial function — mimicking the metabolic benefits of exercise (Lee et al., 2015).
Exercise mimetic: MOTS-c administration in mice improved exercise performance, enhanced insulin sensitivity, and prevented age-related metabolic decline, leading to its characterization as an exercise-mimetic peptide.
Nuclear translocation: Under metabolic stress, MOTS-c translocates from the cytoplasm to the nucleus, where it directly regulates gene expression related to antioxidant response elements (AREs) through interaction with the AMPK-Nrf2 pathway (Kim et al., 2018).
Age-related decline: Circulating MOTS-c levels decline with age, paralleling the decline in mitochondrial function and metabolic efficiency (D'Souza et al., 2020). This decline may contribute to age-related metabolic dysfunction and insulin resistance.
SS-31 (Elamipretide): Mitochondrial Membrane Stabilization
Background
SS-31 (D-Arg-Dmt-Lys-Phe-NH2, also known as Elamipretide or Bendavia) is a cell-permeable tetrapeptide that targets the inner mitochondrial membrane — the site of oxidative phosphorylation and the primary source of cellular energy production.
Mechanisms
Cardiolipin stabilization: SS-31 selectively binds cardiolipin, a phospholipid unique to the inner mitochondrial membrane that is essential for the structural organization of electron transport chain complexes (Szeto, 2014). By stabilizing cardiolipin, SS-31 maintains the efficiency of electron transfer and reduces electron leak that produces damaging reactive oxygen species.
ROS reduction: By optimizing electron transport chain efficiency, SS-31 reduces the production of mitochondrial reactive oxygen species (ROS) at their source, rather than scavenging them after they are produced — a mechanistically superior approach to antioxidant protection (Zhao et al., 2004).
ATP production: Improved electron transport chain efficiency translates directly to increased ATP production per unit of oxygen consumed, restoring the energy output of aging mitochondria.
Clinical development: SS-31 has progressed into clinical trials for mitochondrial myopathy (Barth syndrome), heart failure, and age-related mitochondrial dysfunction, making it one of the most clinically advanced longevity peptides.
Hallmarks Addressed
- Telomere attrition: Epithalon (telomerase activation)
- Mitochondrial dysfunction: NAD+ (sirtuin-mediated biogenesis), MOTS-c (AMPK metabolic optimization), SS-31 (membrane stabilization)
- Deregulated nutrient sensing: MOTS-c (AMPK activation), NAD+ (sirtuin metabolic regulation)
- Cellular senescence: Epithalon (telomere maintenance prevents replicative senescence)
- Epigenetic alterations: NAD+ (sirtuin-mediated deacetylation)
This article is for educational and informational purposes only. BeaCapra supplies research peptides for laboratory and research use. Nothing in this article constitutes medical advice.